Delay in continuous renal replacement therapy initiation linked to worse major adverse kidney events among adolescents and adults
The early or accelerated CRRT initiation strategy among adults with a history of acute kidney injury or volume overload has not demonstrated a survival benefit. There needs to be more data on the association of the timing of CRRT initiation with outcomes among children and young adults.
An Original Investigation on Nephrology published in JAMA Network Open has concluded that delaying the initiation of continuous renal replacement therapy (CRRT) in critically ill children increases the risk of adverse events. This includes death, dialysis dependence, and persistent kidney dysfunction at 90 days.
In this cohort study of 969 patients with data for the primary outcome of MAKE-90, a propensity score–weighted analysis found that each 1-day delay in CRRT initiation was associated with 3% higher odds of MAKE-90.
This retrospective cohort study utilized data from the Worldwide Exploration of Renal Replacement Outcome Collaborative in Kidney Disease (WE-ROCK) registry, collected between 2015 and 2021 across 32 centres in 7 countries. The participants included children and young adults (birth to 25 years) diagnosed with acute kidney injury or VO. The primary exposure was the time from intensive care unit admission to CRRT initiation, and the primary outcome was MAKE-90 (death, dialysis dependence, or persistent kidney dysfunction).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.